ResMed
301 hedge funds and large institutions have $3.59B invested in ResMed in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 90 increasing their positions, 132 reducing their positions, and 37 closing their positions.
64% more call options, than puts
Call options by funds: $120M | Put options by funds: $73.1M
2.49% less ownership
Funds ownership: 54.51% → 52.03% (-2.5%)
4% less funds holding
Funds holding: 313 → 301 (-12)
7% less capital invested
Capital invested by funds: $3.87B → $3.59B (-$280M)
24% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 37
32% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 132
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$34.8M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$33.1M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$32.6M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$16.3M |
| 5 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.7M |
| 2 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$38.9M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$34.2M |
| 4 |
UIM
USS Investment Management
London,
United Kingdom
|
-$22.3M |
| 5 |
HI
Honeywell International
Charlotte,
North Carolina
|
-$20.4M |
RMD Hedge Fund Activity: Q3 2014 in Review
301 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2014, worth a combined $3.59B — down 7.2% from $3.87B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of RMD and 28 opened new positions — a net loss of 9 holders — while 132 trimmed existing stakes and 90 added.
The largest buyer was Invesco, adding an estimated $34.8M. The largest seller was Fidelity Investments, cutting an estimated $78.7M.
- 301 institutional investors held ResMed (RMD) as of Q3 2014, down from 313 in Q2 2014.
- Funds reported $3.59B of ResMed stock for Q3 2014, down 7.2% quarter-over-quarter.
- 28 funds opened new ResMed positions in Q3 2014 and 37 closed out, a net change of -9 holders.
- The largest ResMed buyer in Q3 2014 was Invesco, an estimated $34.8M added.
- The largest ResMed seller in Q3 2014 was Fidelity Investments, an estimated $78.7M sold.
Based on aggregated 13F filings for Q3 2014.